HCC-LM3 Cells
CAD$759.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The HCC-LM3 cell line is an established model for studying hepatocellular carcinoma (HCC), particularly due to its high metastatic potential. This cell line has been instrumental in uncovering mechanisms related to tumor proliferation, migration, and treatment resistance. Research on HCC-LM3 cells has revealed their involvement in exploring drug responses and the molecular pathways influencing cancer aggressiveness. For example, circular RNA circMRPS35 has been shown to play an oncogenic role in HCC-LM3, promoting cell proliferation, migration, invasion, and chemoresistance, particularly to cisplatin. Mechanistically, circMRPS35 functions by sponging microRNA-148a-3p, leading to the upregulation of Syntaxin 3 (STX3), which modulates phosphatase and tensin homolog (PTEN) stability through ubiquitination and degradation. In addition, studies have identified significant metabolic shifts in HCC-LM3 cells that correlate with tumor growth and survival. This cell line, along with other HCC models, demonstrates marked alterations in glucose and lipid metabolism, which support rapid tumor proliferation and are considered hallmarks of liver cancer. Research employing single-cell RNA sequencing has illuminated how metabolic heterogeneity within hepatocyte subpopulations impacts prognosis and therapeutic outcomes. Notably, metabolic pathway analyses in HCC-LM3 have been essential for identifying potential biomarkers and therapeutic targets for improved clinical strategies. |
|---|---|
| Organism | Human |
| Tissue | Liver |
| Disease | Adult hepatocellular carcinoma |
| Metastatic site | Lung |
| Synonyms | HCCLM-3, HCC-LM3, LM3, MHCC-LM3, MHCCLM3 |
Characteristics
| Age | 39 years |
|---|---|
| Gender | Male |
| Ethnicity | Chinese |
| Morphology | Epithelial-like |
| Cell type | Epithelial cells |
| Growth properties | Adherent |
Regulatory Data
| Citation | HCC-LM3 (Cytion catalog number 305504) |
|---|---|
| Biosafety level | 2 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_6832 |
Biomolecular Data
| Protein expression | Albumin+, CK8+ |
|---|---|
| Antigen expression | HBsAg- |
| Oncogenes | AFP+, P53-, P16+, nm23- |
| Viruses | Transformant: Hepatitis B virus (HBV) |
| Mutational profile | Mutation: BRD7, p.Glu277Glyfs*18 (c.830_831delAG); Mutation: KEAP1, p.Pro445Glnfs*13 (c.1334delC); Mutation: TP53, p.Glu51Ter (c.151G>T) |
| Karyotype | Hypotriploid karyotype; Average chromosome number: 55-58 |
Handling
| Culture Medium | DMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 3.7 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 305504-090426 | Certificate of Analysis | 15. May. 2026 | 305504 |